RNA G-quadruplex formed in SARS-CoV-2 used for COVID-19 treatment in animal models

[1]  F. Rodríguez‐Artalejo,et al.  Pharmacological treatment of COVID-19: an opinion paper , 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[2]  G. Gao,et al.  The emergence, genomic diversity and global spread of SARS-CoV-2 , 2021, Nature.

[3]  E. Ruggiero,et al.  G-Quadruplex Targeting in the Fight against Viruses: An Update , 2021, International journal of molecular sciences.

[4]  J. Mergny,et al.  Unlocking G-Quadruplexes as Antiviral Targets , 2021, Pharmacological Reviews.

[5]  D. Stuart,et al.  Antibody evasion by the P.1 strain of SARS-CoV-2 , 2021, Cell.

[6]  Ronald A. Li,et al.  Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 , 2021, Nature.

[7]  Hualiang Jiang,et al.  Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin , 2021, Nature Structural & Molecular Biology.

[8]  Yuquan Wei,et al.  SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model , 2021, Science.

[9]  C. Alabi,et al.  Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets , 2021, Science.

[10]  T. Jiao,et al.  Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase , 2021, Acta Pharmaceutica Sinica B.

[11]  D. Sachs,et al.  Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity , 2021, Immunity.

[12]  L. Flamand,et al.  Antiviral Activity of the G-Quadruplex Ligand TMPyP4 against Herpes Simplex Virus-1 , 2021, Viruses.

[13]  N. Krogan,et al.  Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A , 2021, Science.

[14]  Bikash R. Sahoo,et al.  Inhibition of Zika virus replication by G-quadruplex-binding ligands , 2021, Molecular therapy. Nucleic acids.

[15]  E. Dassi,et al.  G-Quadruplexes in RNA Biology: Recent Advances and Future Directions. , 2020, Trends in biochemical sciences.

[16]  C. Alabi,et al.  Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets , 2020, bioRxiv.

[17]  Leiliang Zhang,et al.  G-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2 , 2020, Frontiers in Microbiology.

[18]  X. Qu,et al.  Targeting RNA G-quadruplex in SARS-CoV-2: A Promising Therapeutic Target for COVID-19? , 2020, Angewandte Chemie.

[19]  F. Ceccherini‐Silberstein,et al.  Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses , 2020, Drug Resistance Updates.

[20]  S. Perlman,et al.  Coronaviruses: An Updated Overview of Their Replication and Pathogenesis , 2020, Methods in molecular biology.

[21]  G. Cheng,et al.  25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor , 2020, Cell Research.

[22]  Geon-Woo Kim,et al.  A Cell-Based Reporter Assay for Screening Inhibitors of MERS Coronavirus RNA-Dependent RNA Polymerase Activity , 2020, Journal of clinical medicine.

[23]  Hongde Liu,et al.  Whole Genome Identification of Potential G-Quadruplexes and Analysis of the G-Quadruplex Binding Domain for SARS-CoV-2 , 2020, bioRxiv.

[24]  Chun Kit Kwok,et al.  Discovery of G-quadruplex-forming sequences in SARS-CoV-2 , 2020, Briefings Bioinform..

[25]  R. Bruno,et al.  Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 , 2020, The New England journal of medicine.

[26]  L. Dodd,et al.  Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.

[27]  S. Balasubramanian,et al.  The regulation and functions of DNA and RNA G-quadruplexes , 2020, Nature Reviews Molecular Cell Biology.

[28]  A. Alisi,et al.  The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19 , 2020, Drugs.

[29]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[30]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[31]  Giovanni Marsico,et al.  Whole genome experimental maps of DNA G-quadruplexes in multiple species , 2019, Nucleic acids research.

[32]  K. Fukunaga,et al.  Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome , 2018, Nature Medicine.

[33]  E. Ruggiero,et al.  G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy , 2018, Nucleic acids research.

[34]  Christophe Jamin,et al.  Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA , 2017, Nature Communications.

[35]  Giorgio Palù,et al.  Visualization of DNA G-quadruplexes in herpes simplex virus 1-infected cells , 2016, Nucleic acids research.

[36]  Xiang Zhou,et al.  Chemical Targeting of a G-Quadruplex RNA in the Ebola Virus L Gene. , 2016, Cell chemical biology.

[37]  S. Richard,et al.  RNA G-quadruplexes and their potential regulatory roles in translation , 2016, Translation.

[38]  Xiang Zhou,et al.  A highly conserved G-rich consensus sequence in hepatitis C virus core gene represents a new anti–hepatitis C target , 2016, Science Advances.

[39]  J. Beaudoin,et al.  Small antisense oligonucleotides against G-quadruplexes: specific mRNA translational switches , 2014, Nucleic acids research.

[40]  Zhenlong Liu,et al.  A cell-based high-throughput approach to identify inhibitors of influenza A virus , 2014, Acta pharmaceutica Sinica. B.

[41]  Jie Zhong,et al.  G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation. , 2014, Nature chemical biology.

[42]  S. Zorzet,et al.  Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies , 2014, Molecular Cancer.

[43]  Jean-Louis Mergny,et al.  Topology of a DNA G-quadruplex structure formed in the HIV-1 promoter: a potential target for anti-HIV drug development. , 2014, Journal of the American Chemical Society.

[44]  Morgan Le Guen,et al.  Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. , 2012, Pharmacology & therapeutics.

[45]  G. Parkinson,et al.  Structural basis for binding of porphyrin to human telomeres. , 2007, Biochemistry.

[46]  E. Raymond,et al.  Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. , 1999, Cancer research.

[47]  Yuquan Wei,et al.  SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model , 2021 .